Case Western Reserve University

Neuros Medical Announces Completion of Enrollment in the QUEST Pivotal Clinical Study for Chronic Post-Amputation Pain

Wednesday, September 15, 2021 - 4:15pm

QUEST is designed to assess the safety & effectiveness of the Company's AltiusHigh-Frequency Nerve Block system to treat intractable post-amputation pain.

Key Points: 
  • QUEST is designed to assess the safety & effectiveness of the Company's AltiusHigh-Frequency Nerve Block system to treat intractable post-amputation pain.
  • Post-amputation pain is a significant unmet medical need, as existing treatment options are limited, and consist primarily of opioids and gabapentinoids.
  • Neuros Medical, a neuromodulation company, has developed the Altius system for the treatment of chronic post-amputation pain (phantom limb pain and residual limb pain).
  • Post-amputation pain includes both phantom limb and residual limb (or "stump") pain, and impacts nearly one million Americans.

Rob Scott Joins Argosy Healthcare Partners

Tuesday, September 7, 2021 - 10:01pm

WAYNE, Pa., Sept. 7, 2021 /PRNewswire/ --Argosy Healthcare Partners ("AHP"), a lower middle market private equity investor focused exclusively on healthcare, and a division of Argosy Capital, a diversified investment firm with $1.9 billion in assets under management ("AUM"), is pleased to announce that Rob Scott has joined its investment team.

Key Points: 
  • WAYNE, Pa., Sept. 7, 2021 /PRNewswire/ --Argosy Healthcare Partners ("AHP"), a lower middle market private equity investor focused exclusively on healthcare, and a division of Argosy Capital, a diversified investment firm with $1.9 billion in assets under management ("AUM"), is pleased to announce that Rob Scott has joined its investment team.
  • Rob began his career as an Analyst at The PFM Group in their healthcare division, where he provided M&A advisory to hospital systems.
  • Rob Scott commented, "I am excited to join AHP and look forward to working with the team to build a best-in-class healthcare platform.
  • Argosy Healthcare Partners ("AHP") is dedicated to partnering with entrepreneurial founders and talented management teams and together building market leading platforms.

ESPERION to Host Investor Webinar on the Current Landscape and Future Directions in the Treatment of Elevated Cholesterol

Tuesday, September 7, 2021 - 9:01pm

ANN ARBOR, Mich., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), the lipid management company, today announced that it will host an investor webinar on the current landscape and future directions in the treatment of elevated cholesterol on Monday, September 13, 2021 at 1:30pm Eastern Time.

Key Points: 
  • ANN ARBOR, Mich., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), the lipid management company, today announced that it will host an investor webinar on the current landscape and future directions in the treatment of elevated cholesterol on Monday, September 13, 2021 at 1:30pm Eastern Time.
  • Dr. Nissen will cover the strengths and limitations of the current treatment paradigm for decreasing cardiovascular disease through lowering of LDL-cholesterol in adults.
  • He will discuss the current landscape, historical evolution of treatment guidelines, and opportunities to bridge the gap in patients not served by current medicines.
  • Additionally, Dr. Nissen will review the role and importance of cardiovascular outcomes trials in characterizing the potential benefits of cardiovascular and LDL-cholesterol lowering medicines.

Azura Ophthalmics Appoints Biopharma Industry Veteran Steven Altschuler, M.D. as Chair of the Board

Tuesday, September 7, 2021 - 1:00pm

Azura Ophthalmics Ltd. , a clinical-stage company developing innovative therapies for Meibomian Gland Dysfunction (MGD) and related eye diseases, today announced the appointment of Steven M. Altschuler, M.D., as chair of its board of directors.

Key Points: 
  • Azura Ophthalmics Ltd. , a clinical-stage company developing innovative therapies for Meibomian Gland Dysfunction (MGD) and related eye diseases, today announced the appointment of Steven M. Altschuler, M.D., as chair of its board of directors.
  • Previously, he co-founded Spark Therapeutics and served as board chair through its progress from private company to IPO and later acquisition by Roche in 2019.
  • We are very pleased to welcome Steven as chair of Azuras board of directors, said Marc Gleeson, chief executive officer of Azura Ophthalmics.
  • Azura Ophthalmics is a clinical-stage company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.

Blue Bird Appoints Razvan Radulescu Chief Financial Officer Effective October 1, 2021

Friday, September 3, 2021 - 5:00pm

Blue Bird Corporation (Blue Bird) (Nasdaq: BLBD), the leading independent designer and manufacturer of school buses, announced today that it has appointed Razvan Radulescu as Chief Financial Officer (CFO).

Key Points: 
  • Blue Bird Corporation (Blue Bird) (Nasdaq: BLBD), the leading independent designer and manufacturer of school buses, announced today that it has appointed Razvan Radulescu as Chief Financial Officer (CFO).
  • Most recently, Razvan served as General Manager of Procurement for Daimler Trucks North America, responsible for all production and aftersales component purchases.
  • Razvan is an accomplished global executive with extensive financial experience in the truck industry and we are very pleased that he will be joining our senior leadership team, said Phil Horlock, Chief Executive Officer of Blue Bird Corporation.
  • Razvan has a proven track record of driving financial and operational performance and he will take over from Phil Tighe (interim CFO) on October 1, 2021.

Versant Health Names Dan Dunkers Senior Vice President and Chief Information Officer

Thursday, September 2, 2021 - 9:30pm

BALTIMORE, Sept. 2, 2021 /PRNewswire/ -- Versant Health , a leading national managed vision care company and wholly-owned subsidiary of MetLife, is proud to announce Dan Dunkers as its Senior Vice President and Chief Information Officer.

Key Points: 
  • BALTIMORE, Sept. 2, 2021 /PRNewswire/ -- Versant Health , a leading national managed vision care company and wholly-owned subsidiary of MetLife, is proud to announce Dan Dunkers as its Senior Vice President and Chief Information Officer.
  • Dan brings more than 30 years of experience in progressive IT, management and business thought leadership to his role, previously serving as Vice President of Information Technology at Johns Hopkins Healthcare.
  • "We are proud to have Dan join us as Chief Information Officer," said James Reid, Chief Executive Officer at Versant Health.
  • Providing vision and eye health solutions that range from routine vision benefits to medical management, Versant Health has a unique visibility and scale across the total eye health value chain.

Performance Food Group Company Appoints Laura Flanagan to Board of Directors

Wednesday, September 1, 2021 - 9:34pm

Performance Food Group Company (PFG) (NYSE: PFGC) announced that it has appointed Laura Flanagan to serve as an independent director on its Board of Directors, effective today.

Key Points: 
  • Performance Food Group Company (PFG) (NYSE: PFGC) announced that it has appointed Laura Flanagan to serve as an independent director on its Board of Directors, effective today.
  • Ms. Flanagan, 53, has served as a Director of Core-Mark Holding Company, Inc. (Core-Mark) since June 2016.
  • I am excited to welcome Laura to our Board of Directors, said George Holm, PFG Chairman, President & Chief Executive Officer.
  • In addition to her Board service with Core-Mark, Ms. Flanagan has served on the Board of Directors of Callaway Golf Company since 2018.

Columbus Metropolitan Housing Authority is the latest Ohio employer to announce a vaccination requirement, helping agency achieve a 90% compliance rate

Wednesday, September 1, 2021 - 2:03pm

Columbus, OH, Sept. 01, 2021 (GLOBE NEWSWIRE) -- The Columbus Metropolitan Housing Authority (CMHA) announced it began implementation of a mandatory vaccination policy for all employees that became effective Monday, Aug. 30, 2021, helping the agency reach a 90% immunization compliance rate.

Key Points: 
  • Columbus, OH, Sept. 01, 2021 (GLOBE NEWSWIRE) -- The Columbus Metropolitan Housing Authority (CMHA) announced it began implementation of a mandatory vaccination policy for all employees that became effective Monday, Aug. 30, 2021, helping the agency reach a 90% immunization compliance rate.
  • CMHA is providing a cash incentive for all 120-plus staff members who receive the vaccine within the agencys identified timeline.
  • CMHAs introduction of the vaccination requirement follows similar announcements by numerous colleges, national retailers and other Ohio businesses that have begun to mandate vaccines.
  • Half of the authority's apartments are set aside as workforce housing for families earning 80% of the area median income.

Cooper Standard Appoints McCabe to Chief Accounting Officer; Conrad to Corporate Controller

Friday, August 27, 2021 - 3:05pm

Cooper Standard Appoints McCabe to Chief Accounting Officer; Conrad to Corporate Controller

Key Points: 
  • Cooper Standard Appoints McCabe to Chief Accounting Officer; Conrad to Corporate Controller
    Cooper Standard (NYSE:CPS) today announced the appointment of two executives to key leadership positions.
  • Rebecca (Becky) McCabe was appointed to vice president, chief accounting officer for the Company, and Linda Conrad was named vice president, corporate controller for the Company.
  • Both executives will be based at the Company's world headquarters in Northville, Michigan and report to Jonathan Banas, executive vice president and chief financial officer, Cooper Standard.
  • Peter Brusate, who has served as the vice president, chief accounting officer and corporate controller since June 2017, is departing the Company in order to pursue other career opportunities.

Excision Announces NIH Martin Delaney Grant Awarded to Temple University to Support “CRISPR for Cure” for HIV

Thursday, August 26, 2021 - 1:00pm

Collaboration with Temple University includes research on EBT-101, a CRISPR-based therapeutic candidate in development as a potential cure for chronic HIV.

Key Points: 
  • Collaboration with Temple University includes research on EBT-101, a CRISPR-based therapeutic candidate in development as a potential cure for chronic HIV.
  • Research will be done at Temple University, as well as the University of California, Los Angeles, Washington University School of Medicine, St. Louis, Case Western Reserve University, Drexel University College of Medicine, and the Scripps Research Institute.
  • In addition to owning the viral gene editing technology that Excision is licensing, Temple University also holds an equity interest in Excision.
  • These interests have been reviewed and approved by Temple University in accordance with its Institutional Conflict of Interest policy.